Literature DB >> 23904858

Diagnosis and office-based treatment of urinary incontinence in adults. Part two: treatment.

Anne P Cameron1, Masahito Jimbo, Joel J Heidelbaugh.   

Abstract

Urinary incontinence is a common problem in both men and women. In this review article we address treatment of the various forms of incontinence with conservative treatments, medical therapy, devices and surgery. The US Preventive Services Task Force, The Cochrane Database of Systematic Reviews, and PubMed were reviewed for articles focusing on urinary incontinence. Conservative therapy with education, fluid and food management, weight loss, timed voiding and pelvic floor physical therapy are all simple office-based treatments for incontinence. Medical therapy for incontinence currently is only available for urgency incontinence in the form of anticholinergic medication. Condom catheters, penile clamps, urethral inserts and pessaries can be helpful in specific situations. Surgical therapies vary depending on the type of incontinence, but are typically offered if conservative measures fail.

Entities:  

Keywords:  Adrenergic beta-3 Receptor Agonists; bladder retraining; lower urinary tract symptoms; muscarinic antagonists; overactive urinary bladder; pelvic floor physical therapy; pessaries; stress urinary incontinence

Year:  2013        PMID: 23904858      PMCID: PMC3721442          DOI: 10.1177/1756287213495100

Source DB:  PubMed          Journal:  Ther Adv Urol        ISSN: 1756-2872


  51 in total

1.  Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature.

Authors:  Mark H Ebell; Jay Siwek; Barry D Weiss; Steven H Woolf; Jeffrey Susman; Bernard Ewigman; Marjorie Bowman
Journal:  J Am Board Fam Pract       Date:  2004 Jan-Feb

2.  Diagnosis and office-based treatment of urinary incontinence in adults. Part one: diagnosis and testing.

Authors:  Anne P Cameron; Joel J Heidelbaugh; Masahito Jimbo
Journal:  Ther Adv Urol       Date:  2013-08

3.  Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: a meta-analysis.

Authors:  M A Harvey; K Baker; G A Wells
Journal:  Am J Obstet Gynecol       Date:  2001-07       Impact factor: 8.661

Review 4.  Which anticholinergic drug for overactive bladder symptoms in adults.

Authors:  J Hay-Smith; P Herbison; G Ellis; A Morris
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

Review 5.  Selective β₃-adrenoceptor agonists for the treatment of overactive bladder.

Authors:  Karl-Erik Andersson; Nancy Martin; Victor Nitti
Journal:  J Urol       Date:  2013-02-28       Impact factor: 7.450

6.  OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial.

Authors:  Victor W Nitti; Roger Dmochowski; Sender Herschorn; Peter Sand; Catherine Thompson; Christopher Nardo; Xiaohong Yan; Cornelia Haag-Molkenteller
Journal:  J Urol       Date:  2012-12-14       Impact factor: 7.450

Review 7.  Timed voiding for the management of urinary incontinence in adults.

Authors:  J Ostaszkiewicz; L Johnston; B Roe
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 8.  Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults.

Authors:  G Peter Herbison; Edwin P Arnold
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

9.  Long-term results of the FemSoft urethral insert for the management of female stress urinary incontinence.

Authors:  L T Sirls; J E Foote; J M Kaufman; D J Lightner; J L Miller; W G Moseley; I E Nygaard; C P Steidle
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2002

Review 10.  Two routes of transobturator tape procedures in stress urinary incontinence: a meta-analysis with direct and indirect comparison of randomized trials.

Authors:  Pallavi M Latthe; Pinki Singh; Richard Foon; Philip Toozs-Hobson
Journal:  BJU Int       Date:  2009-11-12       Impact factor: 5.588

View more
  3 in total

1.  A cross-sectional study on drug use in multiple system atrophy.

Authors:  María Verónica Rey; Santiago Perez-Lloret; Anne Pavy-Le Traon; Wassilios G Meissner; Francois Tison; Olivier Rascol
Journal:  CNS Drugs       Date:  2014-05       Impact factor: 5.749

Review 2.  OnabotulinumtoxinA for the treatment of overactive bladder.

Authors:  Lindsey Cox; Anne P Cameron
Journal:  Res Rep Urol       Date:  2014-07-21

Review 3.  Pessary use in stress urinary incontinence: a review of advantages, complications, patient satisfaction, and quality of life.

Authors:  Ghadeer Al-Shaikh; Sadiqa Syed; Somaia Osman; Abdulrahman Bogis; Ahmed Al-Badr
Journal:  Int J Womens Health       Date:  2018-04-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.